AzTrials
AzTrials

Central SensitizationNCT01705600

Verbalization in Patients With Non-specific Low Back Pain and Central Sensitization

A study testing Pain Verbalization Repression Rules in people with Central Sensitization and Low Back Pain, run by Keystone Rehabilitation Systems at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary goal of this study is to examine the effects of limiting complaints on pain and pain catastrophizing (PC) in individuals with low back pain (LBP) who are in a state of central sensitization (CS). The study will be performed on individuals who have LBP and are in a state of CS. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Pain Verbalization Repression Rules
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
Sep 2012to Aug 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 1. Individuals over the age of 18 who present to physical therapy with a clinical diagnosis of non-specific low back pain.
  • Their pain must also have the one of the following characteristics:
  • 2a.the pain is disproportionate to the nature or extent of injury/pathology AND/OR 2b.the pain is disproportionate, non-mechanical, and unpredictable in response to aggravating/easing factors AND/OR 2c.the pain has a strong association with maladaptive psychological factors AND/OR 2d. the pain is diffuse/non-anatomic areas of pain/tenderness to palpation.

Who cannot join

  • Any red-flags indicating the low back pain is caused by non-musculoskeletal pathology
  • Pain whose origin could be better defined as noceptive (intermittent and sharp with movement or mechanical provocation; pain localized to the area of injury or dysfunction; clear, proportionate mechanical/anatomical nature to aggravating and easing factors; pain described as shooting, burning, sharp, electric-like; pain in association with other dysesthesias; night pain/disturbed sleep; antalgic postures/movement)
  • Pain whose origin could better be defined as peripheral neuropathic (history of nerve injury, pathology or mechanical compromise; pain in a dermatomal or cutaneous distribution; pain/symptoms provocation with movement tests that move or compress neural tissue (ex. SLR)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Keystone Physical Therapy

    Pittsburgh, Pennsylvania, 15017

Other trials in United States

About this study

Official title: Protocol for the Evaluation of the Effects of Limiting Verbal Complaints on Pain and Pain Catastrophizing in Individuals With LBP Who Are in a State of Central Sensitization

The primary goal of this study is to examine the effects of limiting complaints on pain and pain catastrophizing (PC) in individuals with low back pain (LBP) who are in a state of central sensitization (CS).

The study will be performed on individuals who have LBP and are in a state of CS. CS is classified as a type of pain which has the following dominant features: pain that is disproportionate to the nature or extent of injury/pathology; disproportionate, non-mechanical, unpredictable pattern of pain provocation in response to aggravating/easing factors; strong association with maladaptive psychological factors

; diffuse/non-anatomic areas of pain/tenderness to palpation. These criterion have been demonstrated to have discriminative validity for diagnosing CS.

Read the detailed description

This will be a multicenter, randomized (1:1) controlled trial with an experimental and control group. The control group will be treated as the clinician wishes and will be given a bracelet to wear during treatment. The experimental group will be treated as the clinician wishes as well as given a bracelet and a journal with the following instructions:

The goal of this bracelet is to help you recognize your verbal complaints, which we believe may be related to your pain. We are asking that you wear it and follow these rules:

  1. Place the bracelet on either wrist. Please identify in the journal which wrist you have placed it on and the date.
  2. If you verbally complain about Anything, including your pain, switch it to the other wrist, identify the date, wrist switched to, and complaint. Internal complaints and thoughts are allowed.
  3. Indicate if this complaint made you feel better, worse or the same.

We want you to attempt to limit your complaints through altering your wording to express a way in which you could make your situation better. For example, instead of saying "it is way too cold outside" say, "I could have worn more clothes today and I would be less cold".

Participating clinicians will complete a power-point educational session in which they will be trained on the randomization process, the rules of the bracelet and goals of this study. A short education piece on central sensitization will also be provided. Each clinician will consent that they have successfully completed this and understand all aspects of participation. We will also require the clinician to complete a short questionnaire that will ask the following questions:

  1. What is your highest degree of education?
  2. Do you have any board certifications or specializations?
  3. What type of setting do you treat?
  4. How many years have you been a treating clinician?

The clinician will also complete the Pain Attitudes and Beliefs Scale for Physiotherapists (PABS-PT) which is a self-reported measure that discriminates between a biomedical and a biopsychosocial orientation of therapists with regard to low back pain management. The PABS-PT is available in several languages (e.g. English, German, Dutch, Brazilian-Portuguese) and appears to generate reliable and valid data (Ostelo et al., 2003; Laekeman et al., 2008; Magalhães et al., 2011; Mutsaers et al., 2012).

The treating clinician will take pain measurements on the visual analogue scale and pain catastrophizing on the pain catastrophizing scale at week 1, week 4, week 12 and 6-months. The subjects may be discharged when the clinician feels they have successfully achieved goals or have reached plateau. We anticipate discharge to be an average 4-6 weeks after beginning treatment. We are asking that they continue to track progress until 6 months post-enrollment. The clinician will also ask the patient to rate their global rating of change using the GROC scale at discharge. A detailed registration of the type of interventions the clinicians apply will be submitted to the researchers (including the number of treatment sessions) but there is no restriction on how the clinician treats the patient. In addition, we will ask each participant to list the drugs which they are taking (including changes while they are a participant) and any other non-PT interventions they undergo (ie. surgery, injections, etc). This will be crucial for estimating the 'real' treatment effect of the experimental intervention.

Concealed allocation will be performed by using a computer-generated randomized table of numbers created prior to the study. Individual, sequentially numbered index cards with the random assigned numbers would then be prepared. These would be folded and placed in sealed opaque envelopes which each participant would choose. A researcher will then provide a bracelet with or without instructions, depending on group allocation.

The subjects will not be compensated in any way monetarily. The patient will benefit from the study in having satisfaction of providing to the pool of physical therapy research.

Each subject will be verbally explained the study as well as provided a consent form for an agreement of participation. The consent form will highlight the potential risks and benefits of participation. The subject will sign the consent form and this will be filed within the physical therapy facility in which the study is being completed. In addition we will ask the patient that a demographic questionnaire is filled out at baseline that includes the questions:

  1. When did your current episode of back pain begin?
  2. How many episodes of back pain have you experienced in your lifetime?
  3. What is your age?
  4. What is your nationality?
  5. What is your gender?
  6. What is your education level?
  7. Do you expect your back pain will ever resolve?

There are no inherent risks from participation in this study.

The subjects will be a convenience sample who volunteers to participate after being screened by a Physical Therapist. The Physical Therapist would verbally explain the study as well as obtain consent through the attached informed consent forms.

Being tested
Pain Verbalization Repression Rules
Keywords
Central Sensitization, Low Back Pain, Pain, Pain Catastrophizing, Brence
Medical subject headings
Low Back Pain, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pain Verbalization Repression RulesBehavioural

    The involved subjects will be randomized to either a bracelet with receive verbal repression guidelines OR just a bracelet. They will receive typical physical therapy interventions for the treatment of low back pain (modalities, exercise, manual treatment) with the only change being the education of the one group to repress verblization of pain complaints. The bracelet is worn as a reminder of the rules given.

Study groups in NCT01705600
Study groupRoleWhat they receive
Pain Verbalization Repression RulesExperimentalThis group will wear a bracelet with a set of rules which will restrict ones verbalization of pain complaints
Receives: Behavioral: Pain Verbalization Repression Rules

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale for Pain

    This is the visual analogue scale for pain which is routinely used in Physical Therapy practice. The multiple time frames are to assess a change in subjective pain values throughout the study.

    Measured: week 1,4,12, 26

Secondary outcomes (1)
  1. Pain Catastrophizing Scale

    This scale measures catastrophic thoughts often related to prolonged pain. The multiple time frames are to assess a change in subjective values throughout the study.

    Measured: Weeks 1,4,12,26

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Oct 2012 (estimated)
  2. Study startSep 2012
  3. Primary completionAug 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01705600
Sponsor's protocol ID
23210
Status last verified
Oct 2012
First submitted
7 Aug 2012
Last updated
12 Oct 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Pain Verbalization Repression Rules in people with Central Sensitization and Low Back Pain, run by Keystone Rehabilitation Systems at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Oct 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale for Pain (time frame: week 1,4,12, 26). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in